Table 2.
Baseline characteristic of patients excluding preexisting diabetes in each KT and LT groups.
| KT without preexisting DM | LT without preexisting DM | |||
|---|---|---|---|---|
| Non-PTDM | PTDM | Non-PTDM | PTDM | |
| Male/female | 7/4 | 5/3 | 3/2 | 1/0 |
| Age (yr) | 47.9 ± 9.27 | 53.3 ± 9.75 | 45.5 ± 10.27 | 55 |
| Body weight (kg) | 70.9 ± 15.89 | 63.9 ± 8.64 | 57.8 ± 8.67 | 60.1 |
| Height (cm) | 165.2 ± 10.97 | 164.1 ± 5.56 | 161.5 ± 7.27 | 163.2 |
| BMI (kg/m2) | 25.5 ± 3.60 | 23.7 ± 2.45 | 22.1 ± 2.0 | 22.56 |
| Prednisolone (mg) | 10 | 10 | 30 | 30 |
| Tacrolimus (mg) | 4 | 4 | 8 | 8 |
| FBS (mg/dL) | 88.8 ± 16.22 | 117.9 ± 32.66 | 84.8 ± 13.93 | 112 ± 26.8 |
| PPS2hr (mg/dL) | 131.1 ± 63.05 | 185.8 ± 40.31 | 124.3 ± 33.53 | 170 ± 35.5 |
| HbA1c (%) | 4.89 ± 0.62 | 5.18 ± 0.44 | 4.6 ± 0.33 | 4.3 ± 0.42 |
| Insulin (μu/mL) | 6.2 ± 1.9 | 6.6 ± 2.4 | 7.16 ± 2.15 | 7.5 ± 2.5 |
| C-peptide (ng/mL) | 3.4 ± 0.9 | 3.9 ± 1.2 | 3.26 ± 1.2 | 3.78 ± 1.8 |
| T.cholesterol (mg/dL) | 180.5 ± 35.20 | 181.9 ± 20.46 | 145.5 ± 29.22 | ±152 |
| TG (mg/dL) | 132.6 ± 58.98 | 129.1 ± 62.17 | 112.5 ± 41.07 | 76 |
| HDL (mg/dL) | 53.6 ± 20.96 | 59.5 ± 20.46 | 50.8 ± 16.72 | ±68 |
| LDL (mg/dL) | 90.7 ± 19.94 | 91.6 ± 27.53 | 70 ± 30.07 | 71 |